Hemolytic anemias recent advances in diagnosis and treatment.
THE HEMOLYTIC ANEMIAS OF UNKNOWN CAUSE CAN BE SEPARATED INTO TWO MAIN GROUPS: (1) those produced by a defect in cell structure, which is usually hereditary, and (2) those due to a hemolysin of immune-body type.The hemolytic anemias associated with hypersensitivity to drugs and disease processes such as leukemia are less well understood and need further investigation. Splenectomy is the only effective treatment in congenital hemolytic jaundice and in acquired hemolytic anemia; the operation should be carried out promptly in most cases. Transfusion may be used in all varieties of hemolytic disease and is the only effective form of therapy in sickle-cell anemia and paroxysmal nocturnal hemoglobinuria.
D000743:Anemia, Hemolytic; D000745:Anemia, Hemolytic, Congenital; D000755:Anemia, Sickle Cell; D017487:Ankyrins / Q000172:deficiency; D001803:Blood Transfusion; D006457:Hemoglobinuria, Paroxysmal; D006801:Humans; D041781:Jaundice, Obstructive; D013103:Spherocytosis, Hereditary; D013156:Splenectomy; D016896:Treatment Outcome
D017487:Ankyrins
ANEMIA/hemolytic